Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of ‘cures’
Romano Demicheli, Rosalba Miceli, Cristina Brambilla, Laura Ferrari, Angela Moliterni, Milvia Zambetti, Pinuccia Valagussa, Gianni BonadonnaVolume:
53
Langue:
english
Pages:
7
DOI:
10.1023/a:1006134702484
Date:
February, 1999
Fichier:
PDF, 52 KB
english, 1999